CSIMarket
 


Amicus Therapeutics inc   (FOLD)
Other Ticker:  
 

Amicus Therapeutics Inc 's Quick Ratio

FOLD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




FOLD Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities Change 22.11 % -22.64 % 20.03 % 20.94 % 39.24 %
Y / Y Cash & cash equivalent Change 13.04 % -7.8 % -0.99 % -46.22 % -22.69 %
Quick Ratio MRQ 3.42 4.19 4.56 2.86 3.69
Overall Ranking # # # # #
Seq. Current Liabilities Change 12.38 % -10.81 % 3.16 % 18.08 % -28.8 %
Seq. Cash & cash equivalent Change -8.23 % -18 % 64.44 % -8.64 % -25.15 %



Quick Ratio second quarter 2021 Comment
Due to increase in Current Liabilities in the second quarter 2021, Quick Ratio fell to 3.42 below Amicus Therapeutics Inc average.

Within Major Pharmaceutical Preparations industry 253 other companies have achieved higher Quick Ratio than Amicus Therapeutics Inc in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are FOLD Segments?
See Quick Ratio FOLD on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 254
Healthcare Sector # 527
Overall Market # 1235


Quick Ratio Statistics
High Average Low
21.38 6.15 2.48
(Jun 30 2015)   (Sep 30 2016)




Financial Statements
Amicus Therapeutics Inc 's Current Liabilities $ 112 Millions Visit FOLD's Balance sheet
Amicus Therapeutics Inc 's Cash & cash equivalent $ 383 Millions Visit FOLD's Balance sheet
Source of FOLD's Sales Visit FOLD's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Insmed Inc  9.32 $ 928.327  Millions$ 99.656  Millions
Contrafect Corp  9.24 $ 67.499  Millions$ 7.309  Millions
Landos Biopharma Inc   9.19 $ 115.127  Millions$ 12.530  Millions
Larimar Therapeutics Inc   9.18 $ 70.630  Millions$ 7.691  Millions
United Therapeutics Corporation  9.17 $ 1,967.500  Millions$ 214.600  Millions
F star Therapeutics Inc   9.03 $ 81.648  Millions$ 9.041  Millions
Ocuphire Pharma Inc   8.98 $ 24.234  Millions$ 2.699  Millions
Kadmon holdings inc   8.92 $ 270.494  Millions$ 30.318  Millions
Verastem Inc   8.91 $ 108.135  Millions$ 12.134  Millions
Edesa Biotech Inc   8.91 $ 8.053  Millions$ 0.904  Millions
Arbutus Biopharma Corp  8.87 $ 78.379  Millions$ 8.841  Millions
Recro Pharma Inc   8.62 $ 45.724  Millions$ 5.303  Millions
Foghorn Therapeutics Inc   8.61 $ 141.273  Millions$ 16.414  Millions
Zynerba Pharmaceuticals Inc   8.55 $ 85.781  Millions$ 10.028  Millions
Bicycle Therapeutics Plc  8.54 $ 198.738  Millions$ 23.273  Millions
Inspire Medical Systems inc   8.54 $ 207.836  Millions$ 24.350  Millions
Fulcrum Therapeutics inc   8.44 $ 125.550  Millions$ 14.867  Millions
Eton Pharmaceuticals Inc   8.31 $ 25.802  Millions$ 3.106  Millions
Chinook Therapeutics Inc   8.29 $ 197.150  Millions$ 23.770  Millions
Nurix Therapeutics Inc   8.24 $ 386.021  Millions$ 46.844  Millions
Corcept Therapeutics Inc  8.15 $ 369.982  Millions$ 45.402  Millions
Innoviva inc   8.06 $ 43.265  Millions$ 5.371  Millions
Neurobo Pharmaceuticals Inc   8.04 $ 9.513  Millions$ 1.183  Millions
Sesen Bio Inc   8.02 $ 151.036  Millions$ 18.827  Millions
Tricida Inc   7.90 $ 175.766  Millions$ 22.260  Millions
Revance Therapeutics Inc   7.87 $ 336.296  Millions$ 42.740  Millions
Mirum Pharmaceuticals Inc   7.71 $ 223.851  Millions$ 29.028  Millions
Ideaya Biosciences Inc   7.66 $ 274.176  Millions$ 35.771  Millions
Nektar Therapeutics  7.63 $ 1,000.065  Millions$ 131.023  Millions
Prothena Corporation Public Limited Company  7.56 $ 399.831  Millions$ 52.899  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DGNU's Profile

Stock Price

DGNU's Financials

Business Description

Fundamentals

Charts & Quotes

DGNU's News

Suppliers

DGNU's Competitors

Customers & Markets

Economic Indicators

DGNU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071